WS Management’s Abeona Therapeutics ABEO Stock Holding History

WS Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,696	Closed	-$19K	–	76
2022 Q2	$19K	Hold	3,696	–	–	﹤0.01%	78
2022 Q1	$29K	Hold	3,696	–	–	﹤0.01%	70
2021 Q4	$31K	Hold	3,696	–	–	﹤0.01%	63
2021 Q3	$103K	Hold	3,696	–	–	0.01%	72
2021 Q2	$144K	Hold	3,696	–	–	0.01%	74
2021 Q1	$174K	Sell	3,696 -191	-5%	-$10.5K	0.02%	64
2020 Q4	$153K	Hold	3,887	–	–	0.02%	55
2020 Q3	$99K	Hold	3,887	–	–	0.01%	63
2020 Q2	$283K	Sell	3,887 -665	-15%	-$46K	0.03%	55
2020 Q1	$239K	Sell	4,552 -228	-5%	-$15.2K	0.03%	65
2019 Q4	$391K	Hold	4,780	–	–	0.03%	55
2019 Q3	$270K	Sell	4,780 -525	-10%	-$39.3K	0.02%	62
2019 Q2	$634K	Sell	5,305 -625	-11%	-$105K	0.04%	65
2019 Q1	$1.09M	Sell	5,930 -796	-12%	-$142K	0.07%	63
2018 Q4	$1.2M	Sell	6,726 -4,394	-40%	-$958K	0.06%	74
2018 Q3	$3.56M	Hold	11,120	–	–	0.12%	71
2018 Q2	$4.45M	Buy	+11,120	New	+$4.86M	0.13%	61

Other funds holding ABEO

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WS Management's ABEO Position: Q3 2022 in Review

WS Management sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 3,696 shares — an estimated $19K sold.

WS Management first reported a position in ABEO in Q2 2018 and held it in 17 quarters. The position peaked at $4.45M in Q2 2018. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

WS Management reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
WS Management sold 3,696 Abeona Therapeutics shares in Q3 2022, an estimated $19K.
WS Management first reported a position in Abeona Therapeutics in Q2 2018 and held it in 17 quarters.
WS Management's Abeona Therapeutics position peaked at $4.45M in Q2 2018.
24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on WS Management's 13F filing for Q3 2022, filed 14 Nov 2022.